| Literature DB >> 25848626 |
Chatrian Kanger1, Lisanne Brown1, Snigdha Mukherjee1, Haichang Xin2, Mark L Diana3, Anjum Khurshid1.
Abstract
INTRODUCTION: Quality incentive programs, such as Meaningful Use, operate under the assumption that clinical quality measures can be reliably extracted from EHRs. Safety Net providers, particularly Federally Qualified Health Centers and Look-Alikes, tend to be high adopters of EHRs; however, recent reports have shown that only about 9% of FQHCs and Look-Alikes were demonstrating meaningful use as of 2013. Our experience working with the Crescent City Beacon Community (CCBC) found that many health centers relied on chart audits to report quality measures as opposed to electronically generating reports directly from their EHRs due to distrust in the data. This paper describes a step-by-step process for improving the reliability of data extracted from EHRs to increase reliability of quality measure reports, to support quality improvement, and to achieve alignment with national clinical quality reporting requirements.Entities:
Keywords: data use and quality; health information technology; standardized data collection
Year: 2014 PMID: 25848626 PMCID: PMC4371440 DOI: 10.13063/2327-9214.1102
Source DB: PubMed Journal: EGEMS (Wash DC) ISSN: 2327-9214
Practice Characteristics at Start of CCBC Data Standardization Process: March 2011
|
| |
| Federally Qualified Health Center (FQHC) or Look-Alike | 13 |
| Academic/Institution Affiliated | 2 |
| Special Population (e.g., HIV/AIDS) | 1 |
| Private, Nonprofit | 1 |
|
| |
|
| |
| 1–2 | 5 |
| 3–10 | 10 |
| 11–20 | 2 |
|
| |
|
| |
| 13 | |
| (# using Practice Management + EHR) | 12 |
| (# using Practice Management only) | 1 |
| 3 | |
| (# using Practice Management + EHR) | 1 |
| (# using Practice Management only) | 1 |
| 1 | |
| No EHR system | 1 |
|
| |
|
| |
| < 1 year | 2 |
| 1–2 years | 1 |
| 2–5 years | 7 |
| 5+ years | 4 |
| EHR not implemented yet | 3 |
Note:
The CCBC data standardization process focused on the 12 SuccessEHS EHR users and the 1 Aprima site, which was included because Aprima uses Crystal Reports-based software, which is similar to SuccessEHS’s Business Objects reporting software.
Figure 1.CCBC Data Standardization Process
CCBC Diabetes Mellitus (DM) Measures11
| HbA1c Testing | % who received at least one HbA1c test | 007087 | ≥85% |
| HbA1c Poor Control (>9.0) | % whose most recent HbA1c was greater than 9.0% | 007088 | ≤15% |
| HbA1c Control (<8.0) | % whose most recent HbA1c was <8.0% | 007089 | ≥65% |
| HbA1c Control (<7.0) | % whose most recent HbA1c was <7.0% | 007090 | ≥40% |
| BP <140/90 | % whose most recent blood pressure reading was 140/90 mmHg | 007096 | >65% |
| BP <130/80 | % whose most recent blood pressure reading was 130/80 mmHg | 001598 | ≥25% |
| LDL-C testing | % who received had an LDL-C screening performed | 007092 | ≥85% |
| LDL-C<100 | % whose most recent LDL-C value was <100 mg/dL | 007093 | ≥50% |
| Nephropathy | % who received nephropathy screening test or documented evidence of nephropathy | 007094 | ≥85% |
| Foot Exam | % who received foot exam | 001603 | ≥60% |
| Eye Exam | % who received dilated retinal eye exam | 007091 | ≥80% |
CCBC Cardiovascular Disease (CVD) Measures11
| HTN BP<140/90 | % of patients with Hypertension whose most recent BP < 140/90 | PQRI 237 | ≥75% |
| IVD BP <140/90 | % of patients with Ischemic Vascular Disease whose most recent BP <140/90 | PQRI 201 | ≥75% |
| IVD Lipid Profile | % of patients with Ischemic Vascular Disease with Lipid Profile | PQRI 202 | ≥85% |
| IVD Aspirin | % of patients with Ischemic Vascular Disease with documentation of aspirin or other antithrombotic | PQRI 6 | ≥80% |
| IVD Lipid Therapy | % of patients with Coronary Artery Disease who were prescribed lipid-lowering therapy | PQRI 197 | Not applicable |
Figure 2.Mean Data Error Proportions for Diabetes Mellitus Measures among CCBC Clinics over Time
Typology of Common Errors and Its Effects on Diabetes Measure Percentages
| Incorrect visit count parameters | Lower visit count = lower % | National measure specifications require a patient with a diagnosis of DM to have had at least two visits during the measurement period. In this study, it was common for practices to use a higher visit count, which resulted in misleading measure percentage levels. Likewise, restricting measure parameters to patients who had only one visit would likely decrease measure percentage levels. |
| Use of nonstandardized or highly customized Order/CPT codes | Lower % | National measure specifications following standard coding such as ICD-9 and CPT form the basis for inclusion and exclusion criterion in the EHR. In this study it was common that practices had created customized codes without informing the DCs to modify report queries, resulting in lower measure percentage levels. |
| Nonstructured lab data fields | Lower % | Some systems default to nonstructured lab data fields if not set up properly during lab interface development into an EHR. This was found to be a common mistake resulting in unextractable lab values that form the numerator criteria for many of the DM measures. |
| Practice management configurations for uninsured or nonbillable visits | Lower % | In the EHR system that was common to most of the CCBC practices, any report that was tied to a “location” in the data query had to be associated with a financial group. Since some of the CCBC practices provide services to uninsured patients whose visits are not associated with a financial group, those sites experienced a lower percentage level in their DM measures. Another common challenge was found to be that billing staff did not inform DCs when changes were made to financial groups—not realizing their impacts on quality and outcomes reporting. |
| Numerator miscalculation—inclusion criteria: | Lower % | National measures tend to have misleading titles or labels that often lead practitioners to believe that the only populations included in the measures are those that are mentioned in the title. For example, “HbA1c poor control” leads practitioners to count only patients with HbA1c >9.0 (poorly controlled patients), when in fact the measure also includes individuals who did not receive an HbA1c test during the measurement period. Additionally, practitioners may confuse measure requirements with clinical guidelines. For example, blood pressure measurement values must meet criteria for both systolic |
| Denominator miscalculation for ALL HbA1c values | Higher % | National measures specify that the denominator for all HbA1c measure calculations uses the total number of patients with a diagnosis of DM (Type 1 or Type 2) during the reporting period. Once the % of patients with DM who received A1c testing was calculated, it was determined that all practices had mistakenly used that percentage as the denominator to calculate the remainder of their DM measures, such as HbA1c poor control and control, which results in a higher % level for those measures since that value excludes the patients who did not receive HbA1c testing. |
Before and After Error Impacts on Apparent Measure Performance
| HbA1c control (<8.0) | Denominator miscalculation | 7.4% ± 5.6% SD, |
| HbA1c poor control | Numerator and denominator miscalculation | 9.7% ± 6.8% SD, |
Resources Necessary to Implement CCBC’s Data Standardization Process
| Leadership | To be engaged and to allocate personnel time | In-kind |
| Data or QI Manager | Participate in orientation; 1 site visit interview; data workshops; execute and troubleshoot reports using EHR system | 12–40 hrs/per quarter (dependent on no. of practices responsible for, experience and training on system, etc.) |
| Medical Director/Nurse Supervisor/QI Director | Validate data reports | 2 hrs/per quarter |
| Leadership | To prioritize data standardization and to allocate resources | In-kind |
| Data/Evaluation Manager | Develop measure sets; provide technical assistance to practice DCs; coordinate with EHR vendor to build reports and instructional materials | .75 FTE |
| Data Coordinator | Compile clinic data submissions and generate performance feedback reports, graphs, and charts | .25 FTE |
| QI Manager | Provide clinical guidance re: measure sets and EHR system layout | .20 FTE |
| Community User Group (consisting of Medical and QI Directors, research experts, clinicians) | Vet measures; provide recommendations; set priorities for clinical measures (on as-needed basis) | Meet once per month (2 hours) |
| QI/Data Intern | Develop measure reference documentation for educational materials | 1.0 FTE |
| Reporting/Database Design Expert | Build and pretest standardized data reporting templates within EHRs; co-host data workshops; troubleshoot as needed; supply screenshots with user instructions for report templates | 40 hrs total |
Challenges and Solutions to Improving the Reliability of EHR-Generated Clinical Outcomes Reports
| • Lack experienced, dedicated data coordinators | • Engage EHR vendor via data intermediary |
| • Proficiency on EHRs and familiarity with eCQMs and eCQM vocabulary | • Formation of user groups for peer-to-peer learning and group trainings with HIT and data extraction experts |
| • Provider distrust in EHR eCQM data | • Measure reference sheets, data workshops, and webinars to create transparency in measure generation |
| • Translating measure specifications into system fields | • Mapping measure specifications in a spreadsheet with the vendor to specific fields and codes |
| • System upgrades, and users on different versions of the EHR system | • Update and create multiple versions of standard report templates |
| • Lack of standardization in reporting and inconsistent definitions | • Creation of standardized report templates with EHR vendor; development of measure reference sheets and manuals |
| • Lack of data sharing agreements | • Reporting of measure numerators and denominators only |
| • Staying abreast of measure updates given the vast array of measure sets | • Establishing measure consensus among community partners |
| • Ensuring usability and relevance of data reports | • Motivation via performance feedback reports and charts; benchmarking |